Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors (Q28818166)
Jump to navigation
Jump to search
scientific article (publication date: 2017)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors |
scientific article (publication date: 2017) |
Statements
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors (English)
0 references
2017
0 references
10
0 references
463-476
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference